EE106 Cost-Effectiveness Analysis of Belimumab for the Treatment of Adults With Active Lupus Nephritis in China
Jun 1, 2024, 00:00 AM
10.1016/j.jval.2024.03.405
https://www.valueinhealthjournal.com/article/S1098-3015(24)00520-5/fulltext
Section Title :
Section Order :
11750
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(24)00520-5&doi=10.1016/j.jval.2024.03.405